Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis.
about
Overview of the biology of type I interferonsThe interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritisFunction and regulation of retinoic acid-inducible gene-IThe Role of the Transcriptional Regulation of Stromal Cells in Chronic InflammationAssociation of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohortIL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependentGene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5.Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model.Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders.Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosusThe type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritisNucleotide receptor P2RX7 stimulation enhances LPS-induced interferon-β production in murine macrophagesSynergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta.Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance.Type I interferon in organ-targeted autoimmune and inflammatory diseases.IL-22 in tissue-protective therapy.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients.A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats.Kinetic analysis of synovial signalling and gene expression in animal models of arthritis.The RNA-binding protein HuR/ELAVL1 regulates IFN-β mRNA abundance and the type I IFN response.Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisSynoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3.Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Gene and Protein Expression Profiles in a Mouse Model of Collagen-Induced Arthritis.The type I IFN system in rheumatoid arthritis.
P2860
Q21195364-9244ED02-8EE3-4393-9335-F60B9EBBE1A7Q21195412-014F875C-05CC-4579-BFB0-FA550D8079BCQ24632537-CD2B4264-ACD1-4E61-A144-F7D384C6422AQ26778930-87BF7F53-124B-4C9E-BD71-9E13442CD83BQ28271779-760691A0-505F-4F14-BB42-83DE5ECE2634Q28534445-D313F433-BC6E-4153-81B4-E38B4152AC8DQ34188481-A99858AD-326D-4715-9588-ABBA2DE8267FQ34473664-629D023F-CF05-4EEB-8572-CF2FDBC83E04Q34751981-69260CB2-8430-4E8D-9CA8-2799595AB419Q35249619-E26BE641-434B-4E1B-8EE0-EED20D24E866Q35640356-2D5CB71F-1649-4B65-9068-EED9A87612C9Q35953527-80292B16-8948-4A8C-BE7C-BF5A39B1E1EBQ36095071-9E6A6270-5995-4B39-9087-47B126684072Q36338717-8A39AE06-8107-4DE9-A201-19058A1A012BQ36633252-F9BA35D7-A8CD-46B8-9506-2AD399EE5C71Q37058559-5B3101C9-DC6C-45E1-A35C-66C65DCD8069Q37176332-DCB712FC-E54E-458D-A00F-58D330F7630AQ37269317-B9B84758-6298-445A-9E18-77CF1C37A264Q37808291-6713C3C5-48EF-4328-8388-2353A75CD87EQ37838003-4E81F5F9-E1E5-4692-B445-00AA44946374Q38093227-11418CEE-7BC8-41A4-A708-AD5287FBCFC4Q38335622-EAFF7669-5B8D-4DB7-84B8-5EE0375875E5Q39572838-A9E24EF6-7214-4806-9BE5-D7E353E34867Q39915429-1DBF19D9-51B5-49EC-B498-E13BA798293FQ40173296-27F8EFFA-44F1-4B73-B377-5B36F4C846BCQ41441442-B469BC18-9ABF-4FF5-A0E2-5D4570D6CC64Q41632669-EDFC799E-9E0F-4F55-B2EB-2BC6B83C278FQ41902826-599703A3-8218-4925-8EF6-B12CF0B15BDFQ41999154-F5EDFD50-B323-4A63-8797-782F478A3895Q42326768-35BD0349-C7ED-4302-BE31-5914B022875CQ42633541-5B95DAE2-2A88-4879-B36D-032A0DABA477Q49227179-9DAE0290-5CDB-4D76-8DAC-CD31B891A4C3Q53341131-760D6D9E-74B5-4859-A519-DC9BE212092C
P2860
Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expression of interferon beta ...... hritis and reactive arthritis.
@ast
Expression of interferon beta ...... hritis and reactive arthritis.
@en
type
label
Expression of interferon beta ...... hritis and reactive arthritis.
@ast
Expression of interferon beta ...... hritis and reactive arthritis.
@en
prefLabel
Expression of interferon beta ...... hritis and reactive arthritis.
@ast
Expression of interferon beta ...... hritis and reactive arthritis.
@en
P2093
P356
P1476
Expression of interferon beta ...... hritis and reactive arthritis.
@en
P2093
P304
P356
10.1136/ARD.2005.040477
P407
P577
2005-05-05T00:00:00Z